Drugs that contain Leuprolide Acetate

1. Drug name - ELIGARD KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8470359 TOLMAR THERAP Sustained release polymer
Oct, 2023

(1 year, 17 days from now)

CN100536922C TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

CN1474685A TOLMAR THERAP Lupron Polymer Release Preparation With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

CN101669900B TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

CN101669900A TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

EP2158900B1 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Feb, 2019

(3 years ago)

EP2158900A1 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Feb, 2019

(3 years ago)

EP1126822B1 TOLMAR THERAP Controlled Release Liquid Delivery Compositions With Low Initial Drug Burst
Oct, 2019

(2 years ago)

EP1126822A1 TOLMAR THERAP Controlled Release Liquid Delivery Compositions With Low Initial Drug Burst
Oct, 2019

(2 years ago)

EP1322286B1 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1322286B3 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1586309B1 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1322286A2 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1586309A1 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1586309B3 TOLMAR THERAP Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

Treatment: NA

Dosage: POWDER;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
22.5MG POWDER;SUBCUTANEOUS Prescription

2. Drug name - FENSOLVI KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8470359 TOLMAR Sustained release polymer
Oct, 2023

(1 year, 17 days from now)

CN100536922C TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

CN1474685A TOLMAR Lupron Polymer Release Preparation With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

CN101669900B TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

CN101669900A TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 6 days ago)

EP2158900B1 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Feb, 2019

(3 years ago)

EP2158900A1 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Feb, 2019

(3 years ago)

EP1126822B1 TOLMAR Controlled Release Liquid Delivery Compositions With Low Initial Drug Burst
Oct, 2019

(2 years ago)

EP1126822A1 TOLMAR Controlled Release Liquid Delivery Compositions With Low Initial Drug Burst
Oct, 2019

(2 years ago)

EP1322286B1 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1322286B3 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1586309B1 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1322286A2 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1586309A1 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

EP1586309B3 TOLMAR Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
Sep, 2021

(1 year, 7 days ago)

Treatment: NA

Dosage: POWDER;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
45MG POWDER;SUBCUTANEOUS Prescription

3. Drug name - LUPRON DEPOT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8921326 ABBVIE ENDOCRINE INC Sustained-release composition and method for producing the same Feb, 2031

(8 years from now)

Treatment: Palliative treatment of prostate cancer

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
22.5MG/VIAL INJECTABLE;INJECTION Prescription
30MG/VIAL INJECTABLE;INJECTION Prescription
45MG/VIAL INJECTABLE;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.